Bill > SR122

This resolution urges the United States Congress to expand post-traumatic stress disorder (PTSD) treatment for veterans and service members by authorizing stellate ganglion block (SGB) therapy through H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act. The resolution highlights the medical procedure's potential benefits, noting that SGB involves injecting an anesthetic into nerves in the neck that control the "fight or flight" survival reflex and can alleviate PTSD symptoms like hyperarousal and anxiety. The context provided emphasizes the critical need for improved PTSD treatments, as the Department of Veterans Affairs estimates that 29% of Operation Enduring Freedom and Operation Iraqi Freedom veterans have been diagnosed with PTSD, and only 40% find relief from current treatments. The resolution points out that untreated PTSD is correlated with increased suicide risk, with the United States experiencing 20 veteran suicides daily. By supporting H.R. 1947, which would direct the VA and Department of Defense to provide SGB therapy, the resolution aims to offer a promising, low-risk treatment option that has been practiced since the 1920s and was first recognized as a PTSD treatment in 2008.

Military Affairs and Security

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=S&type=R&bn=122